Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience

Tamar Tadmor, MD, Yair Herishanu, MD, Andrei Braester, MD, Osnat Bairey, MD, Ariel Aviv, Naomi Rahimi-Levene, MD, Riva Fineman, MD, Itai Levi, MD, Mona Yuklea, MD, Rosa Ruchlemer, MD, Lev Shvidel, MD, Aaron Polliack, MD

Blood (2018) 132 (Supplement 1): 5566.

https://doi.org/10.1182/blood-2018-99-111681

Published: 2018

Journal Articles

A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group

Tamar Tadmor, MD, Andrei Braester, MD, Najib Dally, MD, Ariel Aviv, Yair Herishanu, MD, Mona Yuklea, MD, Lev Shvidel, MD, Naomi Rahimi-Levene, MD, Rosa Ruchlemer, MD, Ariela Arad, MD, Claudia Fogl, MD, Aaron Polliack, MD, Lee Magal, PhD, Kelly Townsend, PhD

Blood (2018) 132 (Supplement 1): 1849.

https://doi.org/10.1182/blood-2018-99-113771

Published: 2018

Journal Articles

Endothelial Function in Patients with Essential Thrombocytosis.

Maya Koren-Michowitz, MD, Batia Avni, MD, Irma Zur, MD, Yulia Volcheck, MD, Naomi Rahimi-Levene, MD, Victor Dishy, MD, Ahuva Golik, MD, Abraham Kornberg, MD

Blood (2005) 106 (11): 3983.

https://doi.org/10.1182/blood.V106.11.3983.3983

Published: 2005

Journal Articles

Terrorist Attacks: Transfusion Specialists’ Point of View.

Eldad J. Dann, MD, Lilach Bonstein, PhD, Abraham Kornberg, MD, Naomi Rahimi-Levene, MD

Blood (2004) 104 (11): 4103.

https://doi.org/10.1182/blood.V104.11.4103.4103

Published: 2004

Journal Articles

Association of Protein Z Deficiency with Retinal Artery and Vein Occlusion.

Maya Koren-Michowitz, MD, Eva Eting, MD, Yulia Voltchek, MD, Naomi Rahimi-Levene, MD, Osnat Garach-Jehoshua, PhD, Abraham Kornberg, MD

Blood (2004) 104 (11): 3510.

https://doi.org/10.1182/blood.V104.11.3510.3510

Published: 2004

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Diseases Often Discloses Activated Phenotype Pattern.

Adrian Duek, MD, Lev Shvidel, MD, Alain Berrebi, Osnat Bairey, MD, Andre Braester, MD, Naomi Rahimi-Levene, MD

Blood (2004) 104 (11): 4802.

https://doi.org/10.1182/blood.V104.11.4802.4802

Published: 2004

Journal Articles

Enhanced Capacity of Monocytes from Patients with Essential Thrombocytemia to Generate Tissue Factor. Possible Mechanism of Thrombosis.

Abraham Kornberg, MD, Maya Koren-Michowitz, MD, Naomi Rahimi-Levene, MD, Yulia Voltchek, MD, Micha Rapoport, MD

Blood (2004) 104 (11): 1937.

https://doi.org/10.1182/blood.V104.11.1937.1937

Published: 2004

NARROW

Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience

A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group

Endothelial Function in Patients with Essential Thrombocytosis.

Terrorist Attacks: Transfusion Specialists’ Point of View.

Association of Protein Z Deficiency with Retinal Artery and Vein Occlusion.

Chronic Lymphocytic Leukemia Associated with Autoimmune Diseases Often Discloses Activated Phenotype Pattern.

Enhanced Capacity of Monocytes from Patients with Essential Thrombocytemia to Generate Tissue Factor. Possible Mechanism of Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience

A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group

Endothelial Function in Patients with Essential Thrombocytosis.

Terrorist Attacks: Transfusion Specialists’ Point of View.

Association of Protein Z Deficiency with Retinal Artery and Vein Occlusion.

Chronic Lymphocytic Leukemia Associated with Autoimmune Diseases Often Discloses Activated Phenotype Pattern.

Enhanced Capacity of Monocytes from Patients with Essential Thrombocytemia to Generate Tissue Factor. Possible Mechanism of Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only